Drawing for DARIO EVOLVE

USPTO serial 97513368

DARIO EVOLVE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DONEGAN, DANIEL P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DARIO EVOLVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph Agostino

Joseph Agostino GREENBERG TRAURIG, LLP500 Campus Drive, Suite 400Florham Park, NJ 07932UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Disposable test strips for measuring blood sugar for use in conjunction with blood glucose meters; Disposable test strips for measuring blood sugar for use in conjunction with meters for hypertension, weight, musculoskeletal conditions; Medical monitoring devices, namely, diagnostic test strips for use in the fields of blood analysis, hypertension, musculoskeletal conditions, weight and mental condition; Medical monitoring and support devices, namely, diagnostic test strips for use in the fields of chronic conditions, namely, diabetes, hypertension, weight, musculoskeletal conditions, heart conditions, and blood conditions; Medical monitoring devices, namely, diagnostic test strips used in conjunction with medical apparatus for tracking, monitoring, measuring and managing diabetes, blood glucose levels, blood pressure, PH levels and white blood cell concentrationsACTIVE—
009Downloadable medical software for tracking blood data for use in health and wellness treatment and management; Downloadable medical software for patients and healthcare providers to use in collaborating, monitoring, managing, tracking, and communicating concerning health and medical care, wellness, nutrition, weight management, lifestyle management, mental conditions, disease and multiple health and medical conditions treatment and management; Downloadable medical software application for monitoring, tracking and managing health and medical conditions, wellness, nutrition, weight management, lifestyle management, mental conditions, disease and multiple health conditions treatment and management; Downloadable medical software application used on phones, tablets and laptops for tracking blood data for use with sensors, meters, monitors and testers, for use in health and wellness monitor, treatment and management; Software as a Medical Device (SaMD), downloadable, for the treatment and management of diabetes and other multiple medical and health conditions by tracking, monitoring and measuring glucose levels, blood pressure, weight, mental conditions, musculoskeletal conditions and other physiological and medical parametersACTIVE—
010Health and wellness condition sensors, meters, monitors and testers, namely, blood glucose meters and blood testing apparatus; Blood glucose meters; blood glucose monitoring system comprised of blood glucose meters, lancets, and glucose test strips; sensors and testing means for medical condition and wellness monitoring and tracking, namely, patient monitoring sensors and blood testing apparatus; Biometric and biofeedback sensors for use in conjunction with blood glucose meters; Biometric and biofeedback sensors and monitors for medical use used for tracking, measuring, monitoring and managing various health and wellness conditions, namely, diabetes, blood glucose levels, blood pressure, hypertension, weight, diet, obesity, nutrition, musculoskeletal conditions, mental conditions and multiple chronic conditions of the foregoing; Monitors and sensors used to measure biometric data for medical use; Bio-sensors being sensors for collecting, compiling and analyzing clinical and biological data, for medical purposes; Medical products, namely, sensors for real time data input apparatus, namely, sensors for gathering human biometric data, blood properties, respiratory events, monitoring heart rate and concentrations in fluids; Medical patient monitoring sensor apparatus for monitoring, tracking and managing various health and wellness conditions, nutrition, weight, and musculoskeletal conditions; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties, respiratory events and other health and wellness conditions, namely diabetes, hypertension, weight and musculoskeletal conditions; Medical apparatus and instruments to measure and monitor blood pressure, cardiac output, musculoskeletal conditions and other physiological and cardiovascular parameters in the nature of heartrate and weight; Medical devices for blood analysis; Meters, monitors and sensors for measuring blood pressure, weight and body movements for use in conjunction with hypertension, musculoskeletal conditions, weight and mental condition; Medical devices for monitoring blood pressure, weight and body movements for hypertension, musculoskeletal conditions, weight and mental condition; Medical devices for tracking, monitoring, and measuring chronic conditions of patients, namely, diabetes, hypertension, weight, musculoskeletal conditions, heart conditions, and blood conditions for supporting such patients with such chronic conditions; Medical apparatus for tracking, monitoring, and measuring physiological and medial parameters, namely, diabetes, blood glucose levels, blood pressure, and PH levels.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 16, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 16, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 12, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 24, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 24, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 24, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 31, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 31, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 31, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 16, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 18, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 18, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2023DOCKASSIGNED TO EXAMINER—
Mar 27, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 27, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 27, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance